Announcements Trials
Browse Landscape

Status

Suspended 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Skin Lesion 1Prostatic Neoplasms 1Margins of Excision 1Adenocarcinoma 1

Interventions

pembrolizumab 8Nivolumab 6Ipilimumab 6cemiplimab 4aldesleukin 3Interleukin-2 3fludarabine 2Specimen Handling 2Niacinamide 2HhAntag691 2Cyclophosphamide 2Blood Specimen Collection 2Biopsy 2trametinib 1spartalizumab 1sonidegib 1pertuzumab 1lifileucel 1four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate) 1fludarabine phosphate 1dabrafenib 1brodalumab 1atezolizumab 1Vitamin A 1Trastuzumab 1Tissue Banks 1Surgical Procedures, Operative 1Sunscreening Agents 1Standard of Care 1Second Harmonic Generation Microscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Skin Neoplasms × Microscopy, Confocal × Clear all
NCT05068310 2024-12-31

Applicability of a Cellular Resolution Full-field OCT Image System for Pigmented and Non-pigmented Skin Tumors

Apollo Medical Optics, Ltd

Recruiting
200 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡